Login / Signup

Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.

Sharon L McDonnellCarole A BaggerlyChristine B FrenchLeo L BaggerlyCedric F GarlandEdward D GorhamBruce W HollisDonald L TrumpJoan M Lappe
Published in: PloS one (2018)
Higher 25(OH)D concentrations were associated with a dose-response decrease in breast cancer risk with concentrations ≥60 ng/ml being most protective.
Keyphrases
  • breast cancer risk
  • clinical trial